These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10708414)

  • 1. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.
    Martín J; Dunn G; Hull R; Patel V; Minor PD
    J Virol; 2000 Apr; 74(7):3001-10. PubMed ID: 10708414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.
    Odoom JK; Yunus Z; Dunn G; Minor PD; Martín J
    J Virol; 2008 Sep; 82(18):9179-90. PubMed ID: 18596089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
    Buttinelli G; Donati V; Fiore S; Marturano J; Plebani A; Balestri P; Soresina AR; Vivarelli R; Delpeyroux F; Martin J; Fiore L
    J Gen Virol; 2003 May; 84(Pt 5):1215-1221. PubMed ID: 12692287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.
    Yang CF; Chen HY; Jorba J; Sun HC; Yang SJ; Lee HC; Huang YC; Lin TY; Chen PJ; Shimizu H; Nishimura Y; Utama A; Pallansch M; Miyamura T; Kew O; Yang JY
    J Virol; 2005 Oct; 79(20):12623-34. PubMed ID: 16188964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
    J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.
    Martín J
    Biologicals; 2006 Jun; 34(2):117-22. PubMed ID: 16650772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration.
    Hara M; Saito Y; Komatsu T; Kodama H; Abo W; Chiba S; Nakao T
    Microbiol Immunol; 1981; 25(9):905-13. PubMed ID: 6273701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.
    Minor PD; John A; Ferguson M; Icenogle JP
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():693-706. PubMed ID: 2420925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
    Blomqvist S; Bruu AL; Stenvik M; Hovi T
    J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
    Bouchard MJ; Lam DH; Racaniello VR
    J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
    J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.
    Gavrilin GV; Cherkasova EA; Lipskaya GY; Kew OM; Agol VI
    J Virol; 2000 Aug; 74(16):7381-90. PubMed ID: 10906191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.